Oracle Investment Management Inc.
CIK:0001012622
Hedge Fund
$199M AUM
14 holdings
Greenwich, CT, United States
Oracle Investment Management Inc is a private hedge fund based in Greenwich, Connecticut, United States. Founded in 1993, the firm specializes in investment management with a focus on healthcare and life sciences sectors. It is led by highly experienced professionals and serves institutional investors. The firm is relatively small, employing around 4 professionals.
Investment Strategy
Oracle Investment Management Inc employs a concentrated, research-driven investment strategy primarily focused on the healthcare sector, including biotechnology, pharmaceuticals, and medical technology. The firm invests through long/short equity positions, seeking to identify undervalued companies and exploit inefficiencies in the sector, leveraging deep sector expertise.
Top Buys
B
BHVNBIOHAVEN LTD-$6.5M
A
ARDXARDELYX INC-$6.2M
P
PLTRPALANTIR TECHNOLOGIES INC+$1.5M
T
TDOCTELADOC HEALTH INC-$1.2M
W
WGSGENEDX HOLDINGS CORP-$752.2K
Top Sells
S
SWTXSPRINGWORKS THERAPEUTICS INC-$23.4M
B
BHVNBIOHAVEN LTD-$6.5M
A
ARDXARDELYX INC-$6.2M
T
TDOCTELADOC HEALTH INC-$1.2M
W
WGSGENEDX HOLDINGS CORP-$752.2K
Top Holdings
W
WGSGENEDX HOLDINGS CORP+58.4%$85.2M
B
BHVNBIOHAVEN LTD+6.5%$9.5M
A
ARDXARDELYX INC+3.8%$5.6M
P
PLTRPALANTIR TECHNOLOGIES INC+2.8%$4.0M
Q
QDELQUIDELORTHO CORP+2.3%$3.4M
Equity Positions (9)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
W WGS | GENEDX HOLDINGS CORP | 58.40% | $85.2M | 922,454 | $8.50 | $92.31 | -$752.2K |
B BHVN | BIOHAVEN LTD | 6.51% | $9.5M | 673,166 | $75.98 | $14.11 | -$6.5M |
A ARDX | ARDELYX INC | 3.85% | $5.6M | 1,430,728 | $5.41 | $3.92 | -$6.2M |
P PLTR | PALANTIR TECHNOLOGIES INC | 2.76% | $4.0M | 29,500 | $40.10 | $136.32 | +$1.5M |
Q QDEL | QUIDELORTHO CORP | 2.34% | $3.4M | 118,291 | $94.29 | $28.82 | -$727.5K |
Industry Allocation
SERVICES-HEALTH SERVICES
+58.4%
PHARMACEUTICAL PREPARATIONS
+16.9%
SERVICES-PREPACKAGED SOFTWARE
+2.8%
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
+2.3%
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
+2.3%